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It has recently been found that caspases not only
function in apoptosis, but are also crucial for nona-
poptotic processes such as NMDA receptor-depen-
dent long-term depression (LTD) of synaptic trans-
mission. It remains unknown, however, how
caspases are activated and how neurons escape
death in LTD. Here we show that caspase-3 is acti-
vated by the BAD-BAX cascade for LTD induction.
This cascade is required specifically for NMDA
receptor-dependent LTD but not for mGluR-LTD,
and its activation is sufficient to induce synaptic
depression. In contrast to apoptosis, however, BAD
is activated only moderately and transiently and BAX
is not translocated to mitochondria, resulting in only
modest caspase-3 activation. We further demon-
strate that the intensity and duration of caspase-3
activation determine whether it leads to cell death or
LTD, thusfine-tuningofcaspase-3activation iscritical
in distinguishing between these two pathways.
INTRODUCTION
Although caspases are well-known for their role in apoptosis
(Pop and Salvesen, 2009), they can also be activated for nona-
poptotic functions, such as for differentiation of lens and muscle
cells (Murray et al., 2008; Weber and Menko, 2005), proliferation
and differentiation of T and B cells (Beisner et al., 2005; Salmena
et al., 2003), developmental pruning of dendrites in Drosophila
neurons (Kuo et al., 2006; Williams et al., 2006), derivation of
induced pluripotent stem cells (Li et al., 2010a), chemotropic
responses of retinal growth cones in Xenopus (Campbell and
Holt, 2003), habituation to repetitive songs in zebra finches
(Huesmann and Clayton, 2006), and modification of synaptic
transmission such as long-term depression (LTD) in hippo-
campal neurons (Li et al., 2010b; Lu et al., 2006). However, the
signaling pathway underlying caspase activation and the ques-
tion of why active caspases do not cause cell death in such non-
apoptotic functions remain largely unexplored.
Here we address these questions in LTD. LTD is a long-lasting
form of synaptic plasticity in neurons, which is the ability of
synapses to change in strength and plays a crucial role in the758 Neuron 70, 758–772, May 26, 2011 ª2011 Elsevier Inc.refinement of neuronal connections during development and in
cognitive functions such as learning and memory (Kessels and
Malinow, 2009; Malenka and Bear, 2004). N-methyl D-aspartate
(NMDA) receptor-dependent LTD is a prototypical form of LTD
that is primarily mediated by the removal of a-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors
from the postsynaptic membrane (Bredt and Nicoll, 2003;
Collingridge et al., 2004; Malenka and Bear, 2004; Shepherd
and Huganir, 2007). This type of LTD involves Ca2+ influx, protein
phosphatases (PP2B/calcineurin and PP1) (Malenka and Bear,
2004), GSK3b (Peineau et al., 2007), small GTPases such as
Rap1 (Zhu et al., 2002) and Rab5 (Brown et al., 2005), and p38
MAP kinase (Zhu et al., 2002). Recently, we reported that in
hippocampal neurons of rodents, caspase-3 is required for
AMPA receptor endocytosis and LTD induction, and that cyto-
chrome c release from mitochondria is necessary for the activa-
tion of caspase-3 (Li et al., 2010b). However, the questions of
how stimulation of NMDA receptors leads to caspase-3 activa-
tion and, importantly, how neurons survive despite caspase-3
activation have not been addressed in detail.
Cytochrome c release from mitochondria in apoptosis is medi-
atedbymitochondrial outermembranepermeabilization (MOMP),
which is regulated bymembers of the B cell lymphoma-2 (BCL-2)
family of proteins (for recent reviews, see Chipuk et al. [2010] and
Youle and Strasser [2008]). Somemembers of this family, such as
BAX and BAK, promote apoptosis, while others, such as BCL-2
and BCL-XL, inhibit apoptosis by antagonizing the pro-apoptotic
BCL-2 familymembers. BAX andBAKaremulti-BCL-2-homology
(BH)domainproteins that formpores inmitochondrialmembranes
during MOMP (Chipuk et al., 2006). In hippocampal and cortical
neurons, BAX is the major pore-forming BCL-2 family protein, as
BAK is not expressed in these cells (Sun et al., 2001; Uo et al.,
2005). In theabsenceof deathsignals, BAX residespredominantly
in the cytosol (Hsu et al., 1997), but upon stimulation of apoptosis,
it translocates to mitochondria (Goping et al., 1998; Wolter et al.,
1997). BAD and BID are two other well-known pro-apoptotic
BCL-2 family proteins that regulate the pore-forming activity of
BAX. BAD is activated by protein phosphatases (Danial, 2008;
Klumpp and Krieglstein, 2002), while BID is activated by proteo-
lytic cleavage (Yin, 2006). Upon activation, BAD translocates to
mitochondria and binds to anti-apoptotic BCL-2 family proteins,
such as BCL-XL, to counteract their inhibition of BAX (Danial,
2008). Likewise, BID migrates to mitochondria upon activation
and promotes the pore-forming activity of BAX (Youle and
Strasser, 2008).
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BAX in LTD induction. By using siRNA-mediated knockdown
and knock-out approaches as well as protein infusions, we
show that the BAD-BAX cascade, but not BID, is both necessary
and sufficient to activate caspase-3 and to induce LTD in hippo-
campal neurons. Intriguingly, activation of the BAD-BAX
cascade is required specifically for NMDA receptor-dependent
LTD, but not for mGluR-LTD. Unlike in apoptosis, however,
BAD is activated to a lower extent and BAX translocation tomito-
chondria is not induced in LTD, leading in turn tomilder caspase-
3 activation. Furthermore, by manipulating the level and duration
of caspase-3 activation, we provide evidence that strong and
prolonged activation of caspase-3 is required to induce cell
death, and modest and transient caspase-3 activation is critical
for preventing cell death in LTD. These findings reveal unexpect-
edly that despite the fact that activation of the BAD-BAX-cas-
pase-3 pathway usually leads to cell death, neurons adopt this
entire pathway for induction of LTD, and underscore the impor-
tance of quantitative differences in caspase-3 activation for
determining the cellular function of this pathway.
RESULTS
BAD and BAX siRNAs Inhibit LTD in CA1 Hippocampal
Neurons
To determine themechanism for caspase-3 activation in LTD, we
first examined whether knocking down the expression of BAD,
BAX and BID would affect LTD, as these proteins activate
caspase-3 in apoptosis. To this end,wegeneratedconstructs ex-
pressing siRNAs that target themRNAs encoding these proteins.
The efficiency and specificity of these siRNAs were tested
against corresponding cDNAs expressed in heterologous cells
and against their endogenous targets in cultured hippocampal
or cortical neurons. As shown in Figure S1 available online, the
siRNAs were highly effective and specific. To test their effect on
synaptic transmission, we biolistically transfected cultured
hippocampal slices with the siRNA constructs along with
a plasmid expressing venus (a YFP mutant) (Nagai et al., 2002)
and measured excitatory postsynaptic currents (EPSCs) evoked
by stimulating the Schaffer collateral pathway. As shown in
Figures 1A–1D and Table S1, the amplitudes of both AMPA and
NMDA receptor-mediated currents (EPSCAMPA and EPSCNMDA,
respectively) were comparable in untransfected cells and in cells
transfected with control or siRNA plasmids. These results indi-
cate that NMDA receptor functions and basal AMPA receptor-
mediated currents are intact in the transfected cells.
We then proceeded to test the effect of siRNAs on NMDA
receptor-dependent LTD induced by a pairing low-frequency
stimulation protocol (see Experimental Procedures). LTD was
blocked by the selective NMDA receptor antagonist APV [(2R)-
amino-5-phosphonovaleric acid](data not shown), confirming
that this stimulation protocol induces NMDA receptor-dependent
LTD. Simultaneouswhole-cell recordingswere conducted in pairs
of transfected and nearby untransfected CA1 neurons in the same
slice. As shown in Figure 1E, LTD as revealed by a reduction of
EPSCs measured 30 min after stimulation was comparable in un-
transfected and control plasmid transfected cells (56 ± 9% of
baseline [preinduction] in untransfected cells; 49 ± 6%of baselinein control plasmid transfected cells; p = 0.52, n = 11 pairs; Fig-
ure 1E). Similarly, LTD was not altered in BID siRNA transfected
cells (62 ± 6% of baseline in untransfected neurons; 61 ± 8% of
baseline in BID siRNA transfected neurons; p = 0.92, n = 10 pairs;
Figure 1F). However, LTD was reduced in neurons transfected
with BAD siRNA (52 ± 6% of baseline in nearby untransfected
neurons; 80 ± 10%of baseline in BAD siRNA transfected neurons;
p = 0.03, n = 9 pairs; Figure 1G) and BAX siRNA (55 ± 6%of base-
line in nearby untransfected neurons; 89 ± 7% of baseline in BAX
siRNA transfected neurons; p = 0.002, n = 11 pairs; Figure 1H).
siRNA-induced LTD inhibition was abolished by cotransfection
of siRNA-resistant BADandBAX constructs that had synonymous
mutations in the siRNA-targeted region (BAD siRNA plus BAD:
66 ± 7% of baseline in transfected neurons, 62 ± 7% of baseline
in nearby untransfected neurons, p = 0.69, n = 10 pairs; BAX
siRNA plus BAX: 57 ± 7% of baseline in transfected neurons,
60 ± 7% of baseline in nearby untransfected neurons, p = 0.77,
n = 10 pairs; Figures S1F and S1G), hence the effect of siRNAs
on LTDwas caused by specific reduction of BAD and BAX. These
results suggest that BAD and BAX, but not BID, are essential for
NMDA receptor-dependent LTD in CA1 neurons.
NMDA Receptor-Dependent LTD Is Abolished in both
BAD Knockout and BAX Knockout Hippocampal Slices
To confirm the results obtained with siRNAs, we examined LTD
in hippocampal slices from 2–3-week-old BAD knockout and
BAX knockout mice. BAD knockout mice show no develop-
mental or histological abnormalities in the brain (Ranger et al.,
2003). In BAX knockout mice, the number of neurons is slightly
increased, but the overall structure of the brain is normal (Forger
et al., 2004; White et al., 1998). To test whether basal synaptic
transmission is altered in BAD knockout and BAX knockout
slices, we analyzed the input-output relationship of Schaffer
collateral-CA1 synapses (Figure S2A), current-voltage curves
of EPSCAMPA (Figure S2B) and EPSCNMDA (Figure S2C), and
the EPSCAMPA to EPSCNMDA ratio (Figure S2D). All of these
measurements were indistinguishable in wild-type, BAD
knockout, and BAX knockout slices. In addition, the expression
of NMDA receptors (subunit NR1, NR2A, and NR2B) and
AMPA receptors (subunit GluR1 and GluR2) in BAD knockout
and BAX knockout slices was comparable to that observed in
wild-type slices (Figure S2E). These results suggest that basal
synaptic transmission and the expression and properties of
AMPA and NMDA receptors are normal in these knockout mice.
We then examined LTD in hippocampal slices prepared from
the knockout mice. By recording the field EPSP (fEPSP) in the
CA1 region, we found that slices from wild-type littermates of
both BAD and BAX knockout mice showed normal LTD after
low-frequency stimulation (1 Hz, 900 pulses) of the Schaffer
collateral pathway, so we pooled the data from all wild-type
slices (84 ± 3%of baseline, n = 10 slices from threemice; Figures
2A and 2B). In both BAD and BAX knockout slices, however,
LTD-induction was blocked (BAD knockout: 98 ± 2%of baseline,
n = 10 slices from three mice, p = 0.001 for knockout versus
wild-type, Figure 2A; BAX knockout: 94 ± 2% of baseline, n =
10 slices from three mice, p = 0.01 for knockout versus wild-
type, Figure 2B). In addition, we tested LTD in postsynaptic-
specific BAX knockout mice generated by crossing a floxedNeuron 70, 758–772, May 26, 2011 ª2011 Elsevier Inc. 759
Figure 1. LTD in CA1 Neurons Is Inhibited by BAD siRNA and BAX siRNA, but Not by BID siRNA
Cultured hippocampal slices were biolistically transfected with the EGFP construct (as a visual marker) and either the empty vector, or a plasmid expressing BAD
siRNA, BAX siRNA or BID siRNA. Transfected and nearby untransfected CA1 neurons were recorded simultaneously in the whole-cell patch-clamp mode 2 days
after transfection.
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strain selectively expressing Cre recombinase in the CA3 region,
but not in the CA1 region (Nakazawa et al., 2002). LTD in the CA1
regionwas comparable in hippocampal slices prepared fromCre
positive and Cre negative littermates (BAXflox/Cre+: 81 ± 3%of
baseline; BAXflox+/+Cre: 79 ± 2% of baseline; BAXflox+/+Cre+:
83 ± 3% of baseline; n = 9 slices from three mice for each group;
Figure S2F), supporting that BAX in the presynaptic neurons was
not required for LTD induction. Hence, the knockout experi-
ments combined with the siRNA experiment indicate that BAD
and BAX are required in postsynaptic neurons for NMDA
receptor-dependent LTD.
To determine whether this requirement is specific to NMDA
receptor-dependent LTD, we also measured long-term potentia-
tion (LTP) and metabotropic glutamate receptor-dependent LTD
(mGluR-LTD) in CA1 neurons of knockout mice. Both LTP and
mGluR-LTD were comparable in wild-type slices prepared from
littermates of BAD or BAX knockout mice, again allowing us to
pool the data from all wild-type slices. LTP induced by two tetanic
stimulations (100 Hz, 1 s) was similar in wild-type, BAD knockout
and BAX knockout slices (wild-type: 163 ± 6% of baseline, n = 10
slices from three mice, Figures 2C and 2D; BAD knockout: 167 ±
9%ofbaseline,n=10slices from threemice,p=0.72 forknockout
versuswild-type, Figure 2C; BAXknockout: 169± 9%of baseline,
n = 10 slices from three mice, p = 0.59 for knockout versus wild-
type, Figure 2D). mGluR-LTD induced by bath application of the
mGluR agonist (S)-3,5-dihydroxyphenylglycine (DHPG; 100 mM
for 20 min) was also similar in all three genotypes (wild-type:
67 ± 6% of baseline, n = 10 slices from 3 mice, Figures 2E and
2F; BAD knockout: 68 ± 4% of baseline, n = 10 slices from three
mice, p = 0.89 for knockout versus wild-type slices, Figure 2E;
BAX knockout: 67 ± 4% of baseline, n = 10 slices from three
mice, p = 1.00 for knockout versus wild-type slices, Figure 2F).
These results suggest that BAD and BAX are required specifically
for NMDA receptor-dependent LTD.
BAD and BAX Are Essential for AMPA Receptor
Internalization and caspase-3 Activation in LTD
The above results clearly indicate that BAD and BAX play crucial
roles in NMDA receptor-dependent LTD. Because AMPA
receptor endocytosis is a critical step in this form of LTD (Colling-
ridge et al., 2004; Malenka and Bear, 2004; Shepherd and Huga-
nir, 2007), we next examined whether BAD and BAX are involved
in AMPA receptor endocytosis using an antibody feeding assay
to analyze the endocytosis of AMPA receptor subunit GluR2
(Li et al., 2010b). Dissociated hippocampal neurons (14 days
in vitro, DIV14) were transfected with BAD, BAX, or BID siRNA
constructs, and 2–3 days later stimulated with NMDA (30 mM
for 5 min, a method to induce ‘‘chemical LTD’’ that shares the
molecular mechanism with electrically induced LTD [Beattie(A–D) Pairwise analysis of the effect of BID siRNA, BAD siRNA and BAX siRNA on
Pairs of transfected and nearby untransfected cells are individually plotted (filled
pairs of transfected and untransfected cells for each construct.
(E–H) LTD was induced by low-frequency stimulation (300 pulses at 1 Hz paired w
nearby untransfected cells normalized to the baseline prior to LTD induction was p
each construct.
See also Figure S1 and Table S1.et al., 2000]). As shown in Figures 3A and 3B, NMDA-induced
GluR2 internalization was significantly reduced by both BAD
and BAX siRNAs, but not by BID or scrambled siRNAs, or by
cotransfection of BAD and BAX siRNAs with siRNA-resistant
BAD and BAX constructs. However, basal internalization of
GluR2, which was measured in the absence of NMDA treatment,
was not altered by transfection of BAD, BAX, or BID siRNA
constructs (Figure 3C). Thus BAD and BAX are required for
NMDA-induced but not basal AMPA receptor internalization.
To complement the siRNA experiments, we also measured
GluR2 internalization in cultured hippocampal neurons prepared
from BAD knockout and BAX knockout mice. As shown in
Figures S3A–S3D, while NMDA treatment (30 mM, 5 min) caused
GluR2 internalization in wild-type neurons, it failed to do so in
BAD and BAX knockout neurons. The cell surface expression
of GluR2 and its basal internalization were also unaffected by
the genotype of the neurons (Figures S3E–S3H). We conclude,
therefore, that BAD and BAX are critical for NMDA receptor-
dependent AMPA receptor endocytosis.
The above results, together with our previous observation that
AMPA receptor internalization and LTD induction depend on
caspase-3 activation (Li et al., 2010b), suggest that BAD and
BAX are involved in caspase-3 activation in LTD. Hence, we
measured active caspase-3 in NMDA-treated (30 mM, 5 min)
BAD knockout and BAX knockout slices, using an antibody
against the active, cleaved form of caspase-3. As shown in Fig-
ure 4, cleaved caspase-3 was elevated in wild-type but not BAD
or BAX knockout slices treated with NMDA. These data suggest
that during NMDA receptor-dependent LTD, BAD and BAX are
required for caspase-3 activation.
BAD and Caspase-3 Are Sufficient to Induce Synaptic
Depression
Having established the role of BAD and BAX in caspase-3 activa-
tion and AMPA receptor internalization during LTD, we then
examined whether BAD and caspase-3 are sufficient to induce
synaptic depression. For this, we loaded active BAD and active
caspase-3 directly into CA1 neurons in wild-type hippocampal
slices by adding the proteins to whole-cell recording pipettes.
Caspase-3 activity was measured using fluorophore-labeled
DEVD (FITC-DEVD) that was perfused as described in the Exper-
imental Procedures. As shown in Figures 5A and 5B, active cas-
pase-3 was elevated by 241 ± 25% after 1 hr of infusion as indi-
cated by the increased fluorescence signal of FITC-DEVD. This
increase was comparable to that seen in NMDA (30 mM, 5min)
treated cells (240 ± 27% at 10 min after treatment; Figures 5A
and 5B). As a consequence of caspase-3 infusion, EPSCs
were reduced (67 ± 5% of baseline at 1 hr of infusion, n = 9 slices
from three mice, p = 0.0001 for comparison of 2 min and 1 hr of
infusion; Figure 5C). In contrast, infusion of deactivated (boiled)basal EPSCAMPA (recorded at 70 mV) and EPSCNMDA (recorded at +40 mV).
circles). Open circles indicate mean ± standard error of mean (SEM), n = 9–11
ith a holding potential of45mV). The EPSC amplitude of transfected cells and
lotted asmean ± SEM, n = 9–11 pairs of transfected and untransfected cells for
Neuron 70, 758–772, May 26, 2011 ª2011 Elsevier Inc. 761
Figure 2. (LFS)-Induced LTD Is Abolished in Hippocampal Slices from BAD Knockout and BAX Knockout Mice
Acute hippocampal slices were prepared fromBAD knockout mice, BAX knockout mice, and their wild-type littermates (2–3 weeks old). fEPSPs were recorded in
the CA1 region.
(A and B) LFS (900 pulses at 1 Hz) was delivered to induce LTD.
(C and D) LTP was induced by two trains of high frequency stimulations (100 pulses at 100 Hz, 20 s interval).
(E and F) mGluR agonist DHPG (100 mM, 20min) was added to the bath solution to inducemGluR-dependent LTD. Representative traces for indicated time points
were shown on the top. Student’s t test was used for statistical analysis. Data are shown as mean ± SEM, n = 10 slices from three mice for each group.
See also Figure S2.
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nucleophile of caspase-3) did not alter EPSCs (Figure 5C). To
monitor the quality of the recordings and the health of the re-
corded cells, we measured the series resistance and input resis-
tance during recording. These parameters remained stable
during the recording period (Figures S4A and S4C), indicating
that the ‘‘run-down’’ of EPSCs was not caused by deterioration762 Neuron 70, 758–772, May 26, 2011 ª2011 Elsevier Inc.or demise of the recorded cells. In conclusion, infusion of active
caspase-3 to a level similar to that induced by NMDA treatment
is sufficient to suppress synaptic transmission.
We then performed similar experiments with recombinant
BAD in its nonphosphorylated, active form. As shown in Figures
5A and 5B, active caspase-3 was increased by 182 ± 18%at 1 hr
of infusion (n = 5, p = 0.0001 for comparison of preinfusion and
Neuron
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active caspase-3 was increased only slightly (119 ± 7% of base-
line at 1hr of infusion, n = 5, p = 0.058 for comparison of preinfu-
sion and 1 hr of infusion). The cells infused with active BAD
showed a run-down of EPSCs (76 ± 7%of baseline at 1 hr of infu-
sion, n = 9 slices from three mice, p = 0.013 for comparison of
2min and 1 hr of infusion), while no such run-downwas observed
in cells infused with deactivated BAD or mutated BAD without
the BH-3 domain throughwhich BAD interactswith antiapoptotic
BCL-2 family proteins (Youle and Strasser, 2008) (Figure 5D). The
series resistance and input resistance were stable during the
experimental period (Figures S4B and S4D), thus excluding cell
death. Taken together, these data show that BAD and cas-
pase-3 are sufficient to suppress synaptic currents.
BAD, BAX, and Caspase-3 Are Sequentially Recruited
to Induce Synaptic Depression
The above experiments established that BAD and BAX are
required for caspase-3 activation and induction of LTD, but not
whether they act in a sequential or a parallel manner. To address
this question, we performed similar infusion experiments as
above with hippocampal slices prepared from mice deficient in
either caspase-3, BAX or BAD. As shown in Figure 5D, although
infusion of active BAD suppressed synaptic currents in wild-type
neurons, it did not alter them significantly in caspase-3 knockout
cells (92 ± 8% of baseline at 1 hr of infusion, n = 9 slices from
three mice, p = 0.42 for comparison of 2 min and 1 hr of infusion).
Likewise, BAD infusion had no significant effect on the EPSCs of
BAX knockout cells (91 ± 7% of baseline at 1 hr of infusion, n = 9
slices from three mice, p = 0.31 for comparison of 2 min and 1 hr
of infusion). Again, the series resistance and input resistance
remained constant during these infusion experiments (FigureS4).
These results indicate that BAD requires BAX and caspase-3 to
suppress synaptic transmission. Furthermore, the impairment of
synaptic depression in BAD knockout and BAX knockout cells
can be rescued by infusing active caspase-3 (EPSCs at 1 hr of
infusion with active caspase-3 in BAD knockout cells: 46 ± 6%
of baseline, n = 9 slices from three mice, p = 0.0001 for compar-
ison of 2 min and 1 hr of infusion; in BAX knockout cells: 52 ± 5%
of baseline, n = 9 slices from three mice, p = 0.0001 for compar-
ison of 2 min and 1 hr of infusion; Figure 5C).
These results, combined with the finding that caspase-3 acti-
vation in LTD depends on BAD and BAX (Figure 4), suggest that
BAD, BAX, and caspase-3 are activated sequentially to induce
synaptic depression.
Differential Activation of the BAD-BAX-Caspase-3
Cascade in LTD and Apoptosis
The above results show that in LTD, caspase-3 activation
requires BAD and BAX, but activation of these proteins usually
leads to cell death. This prompted us to investigate whether
LTD and apoptosis differ in the mechanisms by which the
BAD-BAX-caspase-3 pathway is activated, or in the level of its
activation.
Dephosphorylation and translocation to mitochondria are crit-
ical steps in the activation of BAD during apoptosis. To test
whether BAD is activated by similar mechanisms in LTD, we
analyzed the level of phosphorylated BAD and the amount ofBAD in the mitochondrial fraction. In fact, NMDA treatment
(30 mM for 5min as used for LTD induction) decreased phosphor-
ylated BAD as detected by immunoblotting with an antibody
against BAD phosphorylated at Ser112 (Figures 6A and 6B and
Table S2), but the total amount of BAD was not affected
(Figure S5A). It is notable that the level of phosphorylated BAD
was higher at 30 min than at 10 min after NMDA stimulation
(Figures 6A and 6B), suggesting that dephosphorylated BAD
was rapidly rephosphorylated after NMDA treatment. Concomi-
tant with the decrease in phosphorylated BAD, there was
a transient increase of BAD in the mitochondrial fraction (Figures
6G and 6H). Taken together, these data suggest that BAD
undergoes transient dephosphorylation and mitochondrial
translocation during LTD.
It is known that in apoptosis, BAD can be dephosphorylated
by PP1, PP2A and PP2B/calcineurin. We therefore tested
whether these phosphatases were also involved in BAD
dephosphorylation during LTD. In fact, NMDA-induced dephos-
phorylation of BAD was blocked by okadaic acid (50 nM, an
inhibitor of PP1 and PP2A) and FK506 (50 nM, an inhibitor of
PP2B/calcineurin) (Figures 6C–6F), suggesting that these
phosphatases may be responsible for BAD dephosphorylation
in LTD. Interestingly, PP1 and PP2B/calcineurin are well known
for their roles in the induction of NMDA receptor-dependent
LTD, thus the mechanism that activates BAD is in line with the
canonical pathway for LTD induction.
With respect to the activation of BAX in apoptosis, two
processes are known to lead to an increase in active BAX in
mitochondrial membranes: translocation of BAX activated in
the cytosol to mitochondria, and activation of BAX associated
with the mitochondrial membranes by proapoptotic BCL-2
family proteins such as BAD and BID. We measured the amount
of active BAX in the whole cell lysates of NMDA-treated neurons
(30 mM, 5 min) using immunoprecipitation with the antibody 6A7
that specifically recognizes BAX in the active conformation. It is
known that once activated, BAX translocates to mitochondria
very efficiently (George et al., 2009). Hence, immunoprecipitation
of whole cell lysates with 6A7 measures active BAX predomi-
nantly in mitochondria. The amount of active BAX immunopre-
cipitated by 6A7 from treated cells was higher than that detected
in control cells (Figures 6M and 6N; Table S2). However, we
found, unexpectedly, that the total amount of BAX in the mito-
chondrial fraction was not altered by NMDA treatment (30 mM,
5 min; Figures 6G and 6H; Table S2). This is in contrast to the
mitochondrial recruitment of activated BAX from the cytosol
that is observed during apoptosis.
To compare the levels of active BAD and BAX in LTD and
apoptosis, we treated neurons with actinomycin D (a transcrip-
tion inhibitor) to induce apoptosis. Prolonged incubation with
actinomycin D (10 mM) decreased phosphorylated BAD (Figures
6I and 6J; Table S2), increased BAD in the mitochondrial fraction
(Figures 6K and 6L; Table S2) and enhanced cell death as
detected by propidium iodide (PI) staining (Table S3). The total
amount of BAD was not changed by actinomycin D (Figure S5B).
Notably, both BAD dephosphorylation and translocation tomito-
chondria were induced to a higher level by actinomycin D than by
NMDA (30 mM for 5 min; Figures 6I–6L; Table S2). Actinomycin D
treatment also increased BAX in the mitochondria fractionNeuron 70, 758–772, May 26, 2011 ª2011 Elsevier Inc. 763
Figure 3. NMDA-Induced GluR2 Endocytosis Is Inhibited by BAD siRNA and BAX siRNA, but Not by BID siRNA
Cultured hippocampal neurons (DIV14) were transfected with the b-gal construct (as amarker of transfected cells) and either the empty vector, siRNA constructs,
siRNAs alongwith siRNA-resistant BAD and BAX constructs, or scrRNA constructs. Three days after transfection, NMDA-induced (30 mM, 5min) or basal (without
NMDA treatment) GluR2 endocytosis was analyzed with the ‘‘antibody-feeding’’ assay. Representative images of neurons immunostained for internalized GluR2
and surface-remaining GluR2 are shown in (A). Arrows label transfected neurons. Normalized internalization index (integrated fluorescence intensity of
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Figure 4. NMDA-Induced Caspase-3 Activation Is Abolished in BAD
Knockout and BAX Knockout Hippocampal Slices
Acute hippocampal slices were prepared from BAD knockouts, BAX knock-
outs, and their wild-type littermates (2–3 weeks old), and treated with NMDA
(30 mM, 5min) or left untreated. The CA1 region was removed and lysed. Active
caspase-3 was analyzed by immunoblotting (A) and quantified in (B). n = 3
mice for each group. **p < 0.01 for comparison of treated and untreated slices.
Data are presented as mean ± SEM. Student’s t test was used for statistical
analysis.
Neuron
Nonapoptotic Role of the BAD-BAX-Caspase Pathway(Figures 6K and 6L; Table S2) and elevated active BAX more
robustly than LTD-inducing NMDA treatment (Figures 6M and
6N; Table S2).
The differences in the levels of BAD and BAX activation in LTD
and apoptosis were expected to result in different levels of cas-
pase-3 activation. To determine the activity of caspase-3, we
used the Caspase-Glo 3/7 Assay kit, which in rat hippocampi
only measures caspase-3 activity, as caspase-7 is not detect-
able in this tissue (Li et al., 2010b). In fact, we found that after
NMDA stimulation (30 mM for 5 min), caspase-3 activity reached
a peak at 10 min (Figure 7A; Table S3) and declined by 30 min to
a level close to that observed before treatment (Figure 7A).
Conversely, active caspase-3 was increased to a high level
and stayed high for at least 8 hr in cells treated with 10 mM acti-
nomycin D (Figure 7C; Table S3; data not shown). Thus, unlike in
apoptosis, caspase-3 is activated to a moderate level and only
transiently in LTD as previously reported (Li et al., 2010b).
Taken together, these results suggest that the mechanism for
activation of BAX and the level of activation of the BAD-BAX-cas-
pase-3 cascade are different in LTD and apoptosis.
Level and Duration of Caspase-3 Activation
Are Essential for Induction of Cell Death
The above results led to the hypothesis that the level of activation
of the BAD-BAX-caspase-3 cascade differentiates the functions
of caspase-3 in LTD and cell death. We finally directly tested thisinternalized GluR2/integrated fluorescence intensity of internalized GluR2 plus su
analysis. n = 15 neurons for each group. **p < 0.01, compared to empty vector tra
bars represent 20 mm. See also Figure S3.hypothesis by examining whether commitment to cell death
depends on the intensity and duration of caspase-3 activation.
In our first approach, we treated cultured hippocampal
neurons with a high concentration (100 mM) of NMDA to enhance
caspase-3 activation. To inhibit calpain-mediated cell death
after this NMDA dose, we included a cell-permeable calpain
inhibitor, LLY-FMK (10 mM), in themedium. As shown in Figure 7A
and Table S3, caspase-3 was activated to a greater extent by
100 mM NMDA than by 30 mM NMDA. Its activation reached
a peak at 10 min after treatment and then gradually declined,
but remained higher than the pretreatment level even 60 min
after treatment (Figure 7A). To limit the duration of caspase-3
activation, the broad spectrum cell-permeable caspase inhibitor
Q-VDwas added to the neural medium at 10, 30, and 60min after
NMDA treatment. The proportion of PI positive neurons analyzed
was comparable to that of sham-treated controls in neurons
exposed to elevated active caspase-3 for 10 min or 30 min (Fig-
ure 7B), but in those exposed to elevated active caspase-3 for
60 min, it was significantly higher (Figure 7B; Table S3). These
results suggest that robust and prolonged activation of cas-
pase-3 induces cell death.
If high levels of caspase-3 activity are required to induce cell
death, we would expect that actinomycin D, if made to induce
only a small increase in caspase-3 activity, would not cause
apoptosis. Hence, in a second approach, we treated neurons
with a low dose of actinomycin D (0.1 mM), and found that this
treatment increased caspase-3 activity to a level similar to the
peak level induced by 30 mM NMDA (Figure 7C; Table S3). In
fact, the proportion of PI-positive cells assessed 22 hr after
actinomycin D treatment was similar to that of untreated controls
(Figure 7D; Table S3). These results show that low-level
caspase-3 activation is not adequate to provoke apoptosis.
In a third approach we tested whether prolonged caspase-3
activation at low levels induces apoptosis. To this end, we
employed a repetitive stimulation method with 30 mM NMDA
(see Experimental Procedures). As shown in Figure 7E, the
pattern of caspase-3 activation and its peak levels of activity
were comparable during the first three NMDA stimulations, and
there was no significant increase in PI-positive cells (Figure 7F).
However, after the fourth stimulation, caspase-3 activity reached
a higher level (147 ± 7% of sham-treated controls at 30 min after
the fourth stimulation; Figure 7E), but it did not reach the level
observed after application of 100 mMNMDA (178 ± 8%of control
at 30 min after 100 mM NMDA treatment; Figure 7A). Neverthe-
less, after adding Q-VD to stop caspase-3 activation 30min after
the fourth NMDA stimulation, the proportion of PI positive cells
stained 22 hr later was significantly increased (Figure 7F; Table
S3). Because the higher increase of caspase-3 activity (178 ±
8%) induced by 100 mM NMDA was not sufficient to cause cell
death when lasting for just 30 min (Figures 7A and 7B), it is
unlikely that the 147 ± 7% increase of caspase-3 activity for
30 min after the fourth NMDA stimulation was responsible for
increased cell death; rather, this increase appears to be the
result of prolonged activation of caspase-3. We conclude,rface GluR2) is quantified in (B) and (C). Student’s t test was used for statistical
nsfected cells treated with NMDA. Data are presented as mean ± SEM. Scale
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Figure 5. Active BAD and Active Caspase-3 Suppress Synaptic Transmission in CA1 Neurons
Acute hippocampal slices were prepared fromBAD knockouts, BAX knockouts, caspase-3 knockout, and their wild-type littermates as indicated (2–3weeks old).
Active BAD (30 mg/ml) and active caspase-3 (45 mg/ml) were each loaded into neurons through recording pipettes.
(A and B) Time-lapse analysis of caspase-3 activity in neurons treated with NMDA (30 mM, 5 min), loaded with caspase-3 and loaded with BAD. FITC-DEVD was
perfused for visualization of active caspase-3. Representative images of neurons before treatment and 15 min after NMDA treatment or 60 min after infusion with
caspase-3 or BAD are shown in (A). Arrows in the left column of (A) label a neuron in focus. Note the variable fluorescence intensity in surrounding neurons located
in different planes of focus. Arrows in the middle and right column of (A) indicate infused cells. Caspase-3 activity indicated by integrated intensity of FITC-DEVD
signals is shown in (B). Graphs show mean ± SEM, n = 5 slices for each group.
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3 that prevents cell death in LTD.
DISCUSSION
In this study, we identify a signaling pathway for caspase-3 acti-
vation in LTD and address the intriguing question of how hippo-
campal neurons undergoing LTD avoid cell death despite the
activation of caspase-3. Our findings reveal an unexpected
conservation between the apoptosis and LTD pathways, and
show that fine-tuning of the BAD-BAX-caspase-3 cascade by
modifying its activation mechanism and activation levels and
duration plays an important role in determining its cellular func-
tion. Our results are based on a series of gene knockdown and
knockout experiments, showing that BAD and BAX are required
to activate caspase-3 in NMDA receptor-dependent LTD, and on
the infusion of active BAD and caspase-3, showing that the BAD-
BAX-caspase-3 cascade is sufficient for induction of synaptic
depression in hippocampal neurons.
We further demonstrate that activation of the BAD-BAX-cas-
pase-3 cascade is initiated by PP2B/calcineurin, PP1, and
PP2A. Although in both LTD and apoptosis, the same group of
phosphatases is responsible for BAD activation, it is likely that
phosphatases respond differently to different stimulations.
LTD-inducing stimulations are brief and mild, while stimulations
used to induce apoptosis (e.g., high concentrations of actino-
mycin D or NMDA) are prolonged and strong. In fact, one would
expect that mild, LTD-inducing NMDA stimulations would cause
a lower level of calcium influx than strong, death-inducing NMDA
stimulations. In turn, lower levels of calcium could lead to lower
levels of PP2B/calcineurin activation and therefore only weak
and brief activation of BAD.
The level and duration of BAD activation determine the charac-
teristics of BAX activation during LTD, because our results
suggest that the primary mechanism for BAX activation in LTD
is activation by BAD. In apoptosis, however, translocation of
BAX from the cytosol to mitochondria plays a major role in
enhancing mitochondrial permeabilization and cytochrome c
release, because under physiological conditions, BAX predomi-
nantly resides in the cytosol, with only a minor fraction being
present on mitochondrial membranes (Hsu et al., 1997).
Why the level of BAX in mitochondria is not elevated in LTD
remains unclear. In fact, even during apoptosis, the mechanism
leading to BAX translocation to mitochondria is elusive. It has
been suggested that some apoptotic stimulations induce
sequential phosphorylations of BAX, for instance, by AKT and
GSK3b (Arokium et al., 2007). Phosphorylation could then trigger
a conformational change in BAX, thereby allowing it to interact
with BAX-binding proteins, such as the p53 upregulated modu-
lator of apoptosis (PUMA), which promotes BAX translocation(C and D) Effect of infusing caspase-3 and BAD on EPSCs. CA1 neurons were
phosphorylated BAD (D) were added to the internal solution of the patch pipette. B
boiled BAD (30 mg/ml), and mutated BAD (BAD BH3D, 30 mg/ml) were loaded i
amplitude is shown as mean ± SEM, n = 9 slices from three mice for each group
EPSCs at 2 min and 1 hr.
See also Figure S4.(Zhang et al., 2009). Among the known proteins that regulate
BAX translocation, only GSK-3b is known to be activated in
NMDA receptor-dependent LTD (Peineau et al., 2007). It is
conceivable that additional BAX-interacting proteins necessary
to enable BAX translocation are not sufficiently activated by
stimulations that induce LTD, leading to a lack of BAX accumu-
lation in mitochondria.
By deliberately manipulating caspase-3 activation, our study
also addresses the physiological significance of differential
activation of caspase-3. We found that only strong or extended
activation of caspase-3 (as induced by high concentrations of
actinomycin D or NMDA, or repeated exposure to low concen-
trations of NMDA) can induce cell death, while weak or transient
caspase-3 activation (as induced by low concentrations of
NMDA or actinomycin D, or single application of low concentra-
tions of NMDA) is not sufficient to do so. These findings establish
a causal link between the intensity and duration of caspase-3
activation and whether caspase-3 acts as an inducer of LTD or
an executor of cell death. Actinomycin D is widely used as
a transcription inhibitor. Our data suggest that in addition to tran-
scription, actinomycin D may affect synaptic transmission by
activating caspase-3.
The transient elevation of caspase-3 activity after induction of
LTD suggests the presence of a mechanism capable of rapidly
removing active caspase-3. We have previously shown that
cleaved caspase-3, which represents the active form, exhibits
a rate of decay during LTD (Li et al., 2010b) similar to that of cas-
pase-3 activity reported here. Therefore, it is likely that the
reduction of caspase-3 activity is caused by rapid degradation
of active caspase-3. Potential regulators of caspase degradation
include the X-linked inhibitor of apoptosis protein (XIAP),
a member of the inhibitors of apoptosis (IAP) family known to
act as an ubiquitin- and NEDD8-E3 ligase for caspases (Broemer
et al., 2010; Ditzel et al., 2008).
Because caspase-3 activation is inherently dangerous to a cell,
one might ask how cells may benefit from utilizing the BAD-BAX-
caspase-3 cascade for nonapoptotic functions. In fact, adapting
the mitochondrial apoptotic pathway to activate caspases might
be especially advantageous for nonapoptotic functions that need
to be restricted to particular subcellular locations, such as LTD,
which is confined to stimulated synapses. Mitochondria would
seem to be ideal devices for delivering and restricting caspase
activators to the vicinity of stimulated synapses to ensure
synapse-specific changes, because the motility of mitochondria
is controlled by synaptic activity and intracellular Ca2+, andmito-
chondria tend to accumulate near active synapses (Li et al.,
2004). Our findings that the BAD-BAX-caspase-3 cascade is
sufficient for LTD induction as demonstrated by infusion of active
BAD or caspase-3 into hippocampal neurons and that overex-
pression of BCL-XL, which antagonizes BAD and BAX, inhibitsrecorded in the whole-cell patch-clamp mode. Active caspase-3 (C) or un-
oiled caspase-3 (45 mg/ml), mutated caspase-3 (caspase-3 C163G, 45 mg/ml),
nto wild-type CA1 neurons as controls. In each graph, the normalized EPSC
. Student’s t test was used for statistical analysis. *p < 0.05 for comparison of
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Figure 6. Differential Activation of BAD and BAX in LTD and Apoptosis
Cultured cortical neurons were incubated with 30 mM NMDA for 5 min or 10 mM actinomycin D for 6 hr and lysed at the indicated time points.
(A, B, I, J) BAD dephosphorylation induced byNMDA and actinomycin D. Cell lysates collected at the indicated timewere immunoblotted for phosphorylated BAD
(pBAD-S112) and total BAD (A, I). The ratio of pBAD-S112 to total BAD was quantified in (B) and (J).
(C–F) Inhibition of NMDA-induced BAD dephosphorylation by okadaic acid and FK506. Neurons were incubated with 50 nM okadaic acid or 50 nM FK506 for
15 min before NMDA treatment. Immunoblots of phosphorylated BAD and total BAD (C and E) were quantified in (D) and (F).
(G, H, K, L) Analysis of BAD and BAX in the mitochondrial fraction after treatment with NMDA or actinomycin D. The mitochondrial fraction was prepared from
neurons treated with NMDA or actinomycin D and analyzed by immunoblotting for BAD, BAX and the mitochondrial protein COX IV. Quantification is shown in (H)
and (L).
(M and N) Active BAX analyzed by immunoprecipitation with the 6A7 antibody. Quantification in (N) shows active BAX normalized to total BAX in the input lysate.
n = 3 for all conditions. Graphs show mean ± SEM, *p < 0.05.
See also Figure S5 and Table S2.
Neuron
Nonapoptotic Role of the BAD-BAX-Caspase Pathway
768 Neuron 70, 758–772, May 26, 2011 ª2011 Elsevier Inc.
Figure 7. The Apoptotic Activity of Caspase-3 Is
Dependent on the Intensity and Duration of Its
Activation
Cultured hippocampal neurons (DIV 17) were treated with
NMDA or actinomycin D. Caspase-3 activity was as-
sessed using the Caspase-Glo 3/7 Assay kit and cell death
was analyzed using propidium iodide.
(A) Caspase-3 activity at indicated times after NMDA
treatment.
(B) Cell death induced by treatment with 100 mM NMDA.
Neurons were incubated with 10 mM LLY-FMK (a calpain
inhibitor that prevents calpain-induced cell death) for 1 hr
prior to NMDA treatment. Q-VD (20 mM) was added to the
medium at indicated times, and propidium iodide staining
was conducted 22 hr after NMDA treatment.
(C) Caspase-3 activation induced by 0.1 mM or 10 mM
actinomycin D.
(D) Cell death induced by actinomycin D. Hippocampal
neurons were treated with actinomycin D (at indicated
concentrations) for 2 hr. Cells were incubated with
medium containing Q-VD (20 mM) for 22 hr after actino-
mycin D treatment for propidium iodide staining.
(E and F) Caspase-3 activation and cell death induced by
repetitive NMDA stimulations. Hippocampal neurons were
treated with NMDA (30 mM, 5 min) or sham-treated every
35 min for one to four times. Caspase-3 activity was
measured using the Caspase-Glo 3/7 Assay (E). To
analyze cell death, Q-VD (20 mM) was added to the
medium 30 min after one, two, three, or four NMDA
stimulations. Cell death was measured 22 hr after treat-
ment and was shown in (F). *p < 0.05 for Student’s t test.
Data are presented as mean ± SEM (n = 3).
See also Table S3.
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tance of mitochondria to synaptic plasticity.
Finally, our findings may have implications for other nonapop-
totic cellular processes involving caspases; in none of these
processes are the mechanisms for restricting the apoptotic
function of caspases well understood. Nevertheless, it has
been reported that in lens cell differentiation, for instance,
caspase activation is milder than in apoptosis (Weber and
Menko, 2005). Hence, it is conceivable that weak activation of
caspases, either by alternative mechanisms or by modified
canonical apoptosis pathways, serves as an apoptosis-inhibi-
tory mechanism in other nonapoptotic cellular processes as
well.Neuron 70EXPERIMENTAL PROCEDURES
Knockout Mice, DNA Constructs, and Reagents
BAD knockout mice were generously provided by Dr. Nika
N. Danial (Harvard University). BAX knockout and
caspase-3 knockout mice were purchased from the Jack-
son Laboratory. Annealed oligos containing siRNA or
scrambled (scrRNA) sequences targeted to BAD (siRNA:
GAATGAGCGATGAATTTGA; scrRNA: GGATATTAGAA
GGGATCAT), BAX (siRNA: CTCACCATCTGGAAGAAGA;
scrRNA: GAACCGACGAACGCTTATA) or BID (siRNA:
CTCCTTCTATCATGGAAGA; scrRNA: GCACACCCGTAA
TTTAGTT) were inserted into the pSuper or pLentiLox
3.7 vector. Mutated BAD (A462G, C468T, T471C,
A474G, T477C) and mutated BAX cDNAs (C555G,
C558G, C561T, G567A, G570A) were inserted into theGW1 vector. The following reagents were obtained commercially: anti-BAD
antibody (Cell Signaling Technology), anti-phospho-BAD antibody (Cell
Signaling Technology), anti-caspase-3 antibody (Cell Signaling Technology),
anti-COX IV antibody (Cell Signaling Technology), anti-BAX antibody 6A7
(Sigma), anti-BAX polyclonal antibody (Upstate Cell Signaling Solutions),
anti-BID antibody (Santa Cruz Biotechnology), actinomycin D (Sigma),
FK506 (Alexis Biochemicals), okadaic acid (Sigma), FITC-DEVD (ABD Bio-
quest), propidium iodide (Roche), LLY-FMK (SM Biochemicals), Q-VD (SM
Biochemicals), active caspase-3 (R&D Systems) and BAD protein (Santa
Cruz Biotechnology).
Acute Hippocampal Slice
Mice (2–3 weeks old) were anesthetized by isoflurane overdose followed by
decapitation. The brain was placed in ice-cold artificial cerebrospinal fluid
(ACSF, pH 7.4, gassed with 95% O2/5% CO2), which is composed of, 758–772, May 26, 2011 ª2011 Elsevier Inc. 769
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and 10 D-glucose. Transverse hippocampal slices (350 mm thick) were
prepared in ice-chilled, oxygenated ACSF with a vibrotome (Leica). The CA3
region of the hippocampus was removed surgically. Hippocampal slices
were recovered in ACSF at 30C for 30 min, then at room temperature for
30 min before being transferred to the recording chamber.
Hippocampal Slice Culture
Hippocampal slice cultures were prepared from 6- to 8-day-old Sprague-Daw-
ley rats. After decapitation, the brain was placed immediately in the cold
cutting solution composed of (in mM) 238 sucrose, 2.5 KCl, 26 NaHCO3, 1
NaH2PO4, 5 MgCl2, 11 D-glucose, and 1 CaCl2. Hippocampal slices
(400 mm) were cut with a McIlwain tissue chopper and placed on top of semi-
permeable membrane inserts (Millipore Corporation) in a 6-well plate contain-
ing culture medium (78.8%minimum essential medium, 20% heat-inactivated
horse serum, 25mMHEPES, 10mMD-glucose, 26mMNaHCO3, 2mMCaCl2,
2 mM MgSO4, 0.0012% ascorbic acid, 1 mg/ml insulin; pH 7.3; 320–330
mOsm). Medium was changed every 2 days. No antibiotics were used.
Neurons were biolistically transfected using the gene gun (Helios Gene-gun
system, Bio-Rad) at DIV3-4. Electrophysiological recordings were performed
at 2 days after transfection.
Electrophysiology
The standardmethodwas used. Hippocampal slices were perfusedwith ACSF
(bubbled with 95% O2/5% CO2; 30
C) at the rate of 2 ml/min. Stimulating
electrode was placed on the stratum radiatum in the CA2 area. Stimuli were
delivered to the electrode at 20 s intervals. For field-recordings, recording
pipettes (1–2 MU) were filled with the bath solution and placed in the CA1
region. Tetanic stimuli (100 pulses at 100 Hz, 2 trains at 20 s intervals) were
delivered to induce LTP, while low-frequency stimulations (LFS; 900 pulses
at 1 Hz) were delivered to induce LTD. For whole-cell recordings, 100 mM
bicuculline was added to the ACSF to block GABAA receptors. The patch
pipette (4–7 MU) solution is composed of (in mM) 130 cesium methanesulfo-
nate, 8 NaCl, 4 Mg-ATP, 0.3 Na-GTP, 0.5 EGTA, 10 HEPES, and 5 QX-314
at pH 7.3. EPSCs of CA1 pyramidal cells were recorded at 70 mV.
A 10 min-baseline recording was conducted prior to LTD induction. For
whole-cell recordings in cultured hippocampal slices, 2 mM2-chloroadenosine
was added to the ACSF to prevent bursting. Simultaneous whole-cell record-
ings were obtained from pairs of nearby transfected and untransfected CA1
neuron. LTD was induced by delivering low-frequency stimulations (LFS;
1 Hz) for 300 s at a holding potential of 45 mV. AMPA receptor-mediated
EPSCs (EPSCAMPA) were measured at a holding potential of 70 mV. NMDA
receptor-mediated EPSCs (EPSCNMDA) were measured 50–70 ms after the
peak of EPSCAMPA at a holding potential of +40 mV (Terashima et al., 2004).
The series resistance and input resistance were monitored on-line and
analyzed with the Clampex program off-line. Only cells with a series resistance
of <25 MU and a <10% drift in both series resistance and input resistance
during the recording period were included. Student’s two-tailed t test was
used for statistical analysis (p < 0.05 considered significant).
Neuronal Culture and Transfection
Hippocampal and cortical neuron cultures were prepared from embryonic day
(E) 18–19 rat or mouse embryos as previously described (Sala et al., 2001).
Neurons were seeded on poly-D-lysine (30 mg/ml) and laminin (2 mg/ml) coated
coverslips or plates at a density of 750 cells/mm2. Cultures were grown in
Neurobasal medium (Invitrogen) supplemented with 2% B27 (Invitrogen),
0.5 mM glutamine and 12.5 mM glutamate. Hippocampal neurons were trans-
fected with Lipofectamine 2000 (Invitrogen).
GluR2 Internalization Assay and Surface GluR2 Staining
The internalization assay was performed as described previously (Lee et al.,
2002). Briefly, neurons were incubated with antibodies against the N terminus
of GluR2 (Chemicon) for 15min at 37C, then stimulated with NMDA (30 mM) or
left unstimulated for 5 min. Neurons were fixed with the fixation buffer (4%
formaldehyde and 4% sucrose in PBS) immediately after the stimulation.
Surface-remaining antibody-labeled GluR2 was saturated by incubation with
Alexa Fluor 555-conjugated secondary antibody (Invitrogen). Internalized anti-770 Neuron 70, 758–772, May 26, 2011 ª2011 Elsevier Inc.body-labeled GluR2 was stained with Alexa Fluor 488-conjugated secondary
antibody (Invitrogen) after permeabilization with methanol (20C). For total
GluR2 surface staining, neurons were incubated with antibodies against the
N terminus of GluR2 for 15 min at 37C, then fixed and incubated with Alexa
Fluor 555-conjugated secondary antibody.
Image Acquisition and Image Analysis
Images were acquired with a Zeiss LSM510 confocal microscope with a 633
(NA 1.4) objective. Confocal images were collapsed to make 2D projections.
MetaMorph software (Molecular Devices) was used to measure integrated
fluorescence intensity of internalized receptors and surface-remaining recep-
tors on the dendrite. Statistical analysis was performed using Student’s t test.
All image acquisition and image analysis were done blindly to the treatment.
Preparation of Cytosolic and Mitochondrial Fractions
Cultured cortical neurons (DIV18) were homogenized with a plastic pestle in
microcentrifuge tubes using a motorized homogenizer (20 strokes). The cell
lysate was centrifuged at 5,000 g for 5 min to remove nuclei and unbroken
cells. The supernatant was further centrifuged at 55,000 g for 1 hr to obtain
the cytosolic fraction (supernatant) and mitochondrial fraction (pellet).
Luminescent Assay of Active Caspase-3 and Propidium Iodide
Staining
Caspase-3 activity of cultured hippocampal neurons (DIV18) was analyzed
with the Caspase-Glo 3/7 Assay kit (Promega). Fifty microliters of Caspase-
Glo 3/7 reagents was added to each well of 96-well plates seeded with primary
hippocampal neurons (20,000 cells/well). After mixing and incubation at room
temperature for 30 min, luminescence was measured with a 1420 Multilabel
Counter luminometer (Perkin-Elmer). For propidium iodide staining, cells
were incubated with culture medium containing 2 mg/ml propidium iodide for
15 min, followed by wash with PBS and fixation in 4% formaldehyde. For
repetitive NMDA stimulations, hippocampal neurons were stimulated with
30 mM NMDA for 5 min, returned to medium without NMDA for 30 min, then
subjected to NMDA stimulation again. The stimulation was repeated one to
four times.
Time-Lapse Detection of Active Caspase-3 in Whole-Cell Patched
Neurons
Acute hippocampal slices (from mice at 2–3 weeks of age) were perfused with
FITC-DEVD for 5min followed bywashout for 10min to remove unbound FITC-
DEVD and image acquisition. After the first image was taken, the slice was
perfused with NMDA (30 mM, 5 min) or subject to whole-cell patch clamp for
loading of BAD and caspase-3. Perfusion of FITC-DEVD and image acquisition
were repeated every 15 min. Images were acquired with an Olympus BX61WI
confocal microscope with an UplanSApo 603/1.35 objective during the last
5 min of the washout period.
Preparation of Mutated BAD and Mutated Caspase-3 Proteins
The cDNAs of BAD BH3D (gift of Dr. Richard Youle) and caspase-3 C163G
were inserted into the GB1 vector (gift of Dr. Tsan Xiao) behind the histidine
tag. Proteins were expressed in bacteria and purifiedwith HisTrap HP columns
(GE Healthcare) followed by dialysis to remove imidazole.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and three tables and can be
found with this article online at doi:10.1016/j.neuron.2011.04.004.
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